| DC Field | Value | Language |
|---|
| dc.contributor.author | Gureeva, A. V. | - |
| dc.contributor.author | Severinova, O. V. | - |
| dc.contributor.author | Gureev, V. V. | - |
| dc.contributor.author | Kochkarova, I. S. | - |
| dc.contributor.author | Avdeyeva, E. V. | - |
| dc.date.accessioned | 2023-04-11T06:45:46Z | - |
| dc.date.available | 2023-04-11T06:45:46Z | - |
| dc.date.issued | 2022 | - |
| dc.identifier.citation | Study of the effect of acetylsalicylic acid and a selective arginase II inhibitor KUD 975 on the correction of hemostatic disorders in experimental preeclampsia / A.V. Gureeva [et al.] // Research Results in Pharmacology. - 2022. - Vol.8, №3.-P. 1-8. - Doi: 10.3897/rrpharmacology.8.87539. - Refer.: p. 7-8. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/52716 | - |
| dc.description.abstract | The disruption of the functional state of the vascular endothelium is among the main causes of preeclampsia, which is one of the most common causes of maternal and perinatal mortality. It can be enhanced by the humoral factors secreted by the activated platelets. The use of acetylsalicylic acid is an effective way to prevent preeclampsia | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | selective arginase II inhibitor KUD 975 | ru |
| dc.subject | acetylsalicylic acid | ru |
| dc.subject | preeclampsia | ru |
| dc.subject | platelets | ru |
| dc.title | Study of the effect of acetylsalicylic acid and a selective arginase II inhibitor KUD 975 on the correction of hemostatic disorders in experimental preeclampsia | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 8, № 3
|
